Clinical profiles and HLA haplotypes in patients with severe cutaneous adverse reactions in Lusaka, Zambia
- 30 July 2024
- journal article
- research article
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (2) , 432-433
Abstract
No abstract availableKeywords
Funding Information
- European Commission (TMA2017SF‐1981)
This publication has 4 references indexed in Scilit:
- Long-term HIV and tuberculosis outcomes in patients hospitalised with severe cutaneous adverse reactionsJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2023
- Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020Frontiers in Medicine, 2022
- Incidence of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in an HIV CohortAmerican Journal of Clinical Dermatology, 2012
- Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-StudyJournal of Investigative Dermatology, 2008